Insignis Therapeutics Announces Positive Results from Phase 1 Clinical Study of IN-001 Liquid Epinephrine Sublingual Spray for Anaphylaxis
Rapid epinephrine absorption with a time to reach the 100 pg/mL threshold concentration in 9 minutes after dosingSustained pharmacokinetics (PK)...